Repeat pull from proven relationships plus room left: the installed base is expanding on its own initiative and is still
The model's full reasoning — Q1 2017 call → NO我们根据提供的财报电话会议记录回答问题。问题要求判断管理层是否描述了现有客户/合作伙伴已经主动采取或承诺更多业务(扩大规模、增加站点、产品、范围等),并且这些关系仍然渗透不足,还有很大增长空间。需要两个条件都满足:1) 现有关系中的实际扩张行为已经发生,由对方主动选择;2) 管理层明确表示这些关系中仍有大量空间。 在记录中,关于SPINRAZA,管理层提到Biogen报告第一季度销售额超过4700万美元,超出预期,并且获得欧洲CHMP积极意见,预计欧盟批准。但这是关于新市场(欧盟)的扩张,不是现有关系中的扩张。关于现有关系,例如与Bayer的合作,Bayer支付了7500万美元推进两个药物,这可能是现有合作的扩展,但这是新项目,不是现有产品扩大使用。与Novartis的合作是新的。关于volanesorsen,Akcea准备提交申请,但尚未上市。 关键点:管理层是否描述了现有合作伙伴(如Biogen)在现有关系内主动增加更多?SPINRAZA的销售增长是现有产品在现有市场的销售增长,但这是商业销售,不是合作伙伴主动扩大范围。管理层提到Biogen正在扩大站点(从40-50个中心到88个站点),这可能是现有关系的扩展,但这是Biogen自己的商业活动,不是Ionis直接描述的“现有关系中的扩张”。另外,管理层提到“随着SPINRAZA销售增长,我们的版税也会增加”,但这是销售增长,不是合作伙伴主动承诺更多。 关于“轻渗透”部分,管理层没有明确说现有关系还有多少空间。例如,对于SPINRAZA,管理层说“我们相信SPINRAZA有重磅潜力”,但这是对整体市场的预期,不是对现有关系渗透不足的表述。对于volanesorsen,管理层说FCS患者约3000-5000人,但这是新市场。 整体上,管理层主要谈论新合作、新市场、新药物,没有明确描述现有合作伙伴(如Biogen)在现有关系内主动扩大规模(如增加适应症、增加地区)并且这些关系仍有很多空间。虽然Biogen在扩大站点,但这是商业推广,不是Ionis直接说的“现有关系中的扩张”。而且管理层没有说这些关系渗透不足。 因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PPC | Pilgrim's Pride Corporation | Q1 2024 | 2024-05-03 | A |
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| CALX | Calix, Inc. | Q1 2023 | 2023-04-20 | C+ |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| DM | Desktop Metal, Inc. | Q2 2022 | 2022-08-08 | F |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| FARM | Farmer Bros. Co. | Q3 2022 | 2022-05-07 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| SOPH | SOPHiA GENETICS SA | Q4 2021 | 2022-03-15 | C |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| TENB | Tenable Holdings, Inc. | Q2 2021 | 2021-07-27 | A |
| DGX | Quest Diagnostics Incorporated | Q2 2021 | 2021-07-22 | B+ |
| ADSK | Autodesk, Inc. | Q3 2019 | 2018-11-20 | A |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| ORAN | Orange SA | Q2 2018 | 2018-07-26 | B |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| CVS | CVS Health Corporation | Q1 2018 | 2018-05-02 | B+ |
| BCOV | Brightcove Inc. | Q1 2018 | 2018-04-26 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
| UPLD | Upland Software, Inc. | Q4 2017 | 2018-03-08 | C+ |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| CCOI | Cogent Communications Holdings, Inc. | Q2 2017 | 2017-08-03 | B |
| PTC | PTC Inc. | Q3 2017 | 2017-07-19 | C+ |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| WK | Workiva Inc. | Q4 2015 | 2016-03-01 | B |
ZVIA · Q1 2022 → YESThe question is about whether management describes existing customers taking more from the company on their own initiative, and that these relationships are still lightly penetrated. YES Management describes existing customers (households and Club channel buyers) already taking meaningfully more through velocity (51% of growth), higher buy rates (+9%), and heavier consumption in the food channel, while conveying that these relationships remain lightly penetrated with substantial room ahead (new households, expanded flavors, broader deployments). This is 100% present-tense, driven by counterparties’ own choice after direct experience, not price hikes or auto-renewal, and the expansion is already occurring across multiple accounts rather than isolated or projected.
PI · Q4 2022 → YESThe question is about whether management describes existing customers expanding their business with the company, and that these relationships are still lightly penetrated. YES The transcript shows management describing existing customers expanding through program expansions, broader deployments, and continued system deployments that are already occurring and expected to drive large volumes in 2023 and beyond, while conveying that these relationships remain lightly penetrated with substantial room for further growth in scope, sites, and usage.
CVS · Q1 2018 → YESThe question is about whether management describes existing customers taking more from the company on their own initiative, and that these relationships are still lightly penetrated. YES The transcript shows management describing existing partnerships (Optum and Cigna clients) already taking more programs through an uptick in CVS Pharmacy and MinuteClinic offerings, driven by the companies' own adoption after experience, with continued opportunities for 2020 and beyond indicating substantial room remains in those relationships.